Pediatric Urodynamic Study Without a Preprocedural Urine Culture, Is It Safe in Clinical Practice?


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
11 2020
Historique:
received: 28 05 2020
revised: 27 07 2020
accepted: 29 07 2020
pubmed: 12 8 2020
medline: 25 2 2022
entrez: 12 8 2020
Statut: ppublish

Résumé

To prove that incidence of UTI after a pediatric urodynamic study (UDS) is low, and that patients without urine culture (UC) analysis prior to a UDS will not have a significant increase in the incidence of UTI (post-UDS UTI). Prospective cohort study including consecutive pediatric patients undergoing UDS in a single center for 1 year. Patients were divided in 2 groups: (G1) UDS with a previous negative UC and (G2) UDS without a previous UC analysis. A clean UC was obtained in all patients at the moment of the UDS (UDS-UC). Primary outcome was post-UDS UTI. Secondary outcome was to compare UC cost per patient and cancellation rates in each group. All patients were followed 15 days after the UDS to detect onset of UTI symptoms. Four hundred two patients were included, 198 patients in G1 and 204 patients in G2. Median age was 9 years old. Both groups were similar in terms of demographic and clinical records data except for a proportion of patients on CIC which was larger in G2 (P <.008). Overall incidence of post-UDS UTI was 0.7% (3/402), G2 incidence (0.98%) being slightly higher than G1 (0.50%; P <.58). UDS-UC was positive in 32% of G1 vs 55% in G2 (P <.001). About 98% of patients with positive UDS-UC did not progress to symptomatic UTI. G1 cost was 140% higher than G2. Overall incidence of post-UDS UTI is low (0.7%). Patients without UC prior to UDS did not have a significant increase in post-UDS UTI.

Identifiants

pubmed: 32781080
pii: S0090-4295(20)30965-1
doi: 10.1016/j.urology.2020.07.054
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

224-228

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Felicitas Lopez Imizcoz (F)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina. Electronic address: felicitaslopezimizcoz@gmail.com.

Carol Maria Burek (CM)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

Cristian Sager (C)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

Mariana Vasquez Patiño (M)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

Yesica Ruth Gomez (YR)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

María Tatiana Szklarz (MT)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

Catalina Tessi (C)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

Javier Ruiz (J)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

Santiago Weller (S)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

Juan Pablo Corbetta (JP)

Urology Department ¨Prof. Dr. Juan P. Garrahan¨ Pediatric Hospital, Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH